WHITHOUSE STATION – Merck commonly called a MSD in United States told that Food and Drug Administration has given green signal to ZIOPTAN(TM). ZIOPATAN is used in to deduce the effects of elevated intraocular pressure (IOP) in patients with Ocular hypertension. The FDA approved the medication after there was a two year clinical research of almost 905 subjects. The clinical research it was found that ZIOPTAN has IOP lowering effect. Merck has told that ZIOPTAN will be sold to customers till March.
Information about the ZIOPTAN
ZIOPTAN makes alterations in pigmented tissues. The pigmentation has increased in iris pigmentation, periorbital tissue, and eye lashes. The ZIOPTAN should be used with caution with aphakic patients as high risk is involved in it. The further study needs to be done whether pregnant women should be allowed to take ZIOPTAN. The fetus may in any way be in danger due to the use of ZIOPTAN the researchers are dealing with that issue. The pediatric patients are barred to use ZIOPTAN as there is long term implication associated with that kind of patients.
Recommended Usage of ZIOPTAN
The recommended dosage is one drop of ZIOPTAN in conjunctival sac of eye of patients daily in the evening.
Agreement among Merck and Santen It was on 15, April, 2009 that both the pharmacy company collaborated together for Tafluprost. Merck has commercial rights in North America, South Africa, Western Europe, Middle East, Australia and many more area around the world. The Santen handles the market in places like Germany, countries of Asia Pacific, Northern Europe and many more.
Information regarding Merck and Santen
The Merck is a huge world wide healthcare company. The Merck works with more than 140 countries to give them health solutions. The Santen Is a pharmacy company which has its base in Osaka and works in fields ophthalmic, eyesight, and health.
Information about the ZIOPTAN
ZIOPTAN makes alterations in pigmented tissues. The pigmentation has increased in iris pigmentation, periorbital tissue, and eye lashes. The ZIOPTAN should be used with caution with aphakic patients as high risk is involved in it. The further study needs to be done whether pregnant women should be allowed to take ZIOPTAN. The fetus may in any way be in danger due to the use of ZIOPTAN the researchers are dealing with that issue. The pediatric patients are barred to use ZIOPTAN as there is long term implication associated with that kind of patients.
Recommended Usage of ZIOPTAN
The recommended dosage is one drop of ZIOPTAN in conjunctival sac of eye of patients daily in the evening.
Agreement among Merck and Santen It was on 15, April, 2009 that both the pharmacy company collaborated together for Tafluprost. Merck has commercial rights in North America, South Africa, Western Europe, Middle East, Australia and many more area around the world. The Santen handles the market in places like Germany, countries of Asia Pacific, Northern Europe and many more.
Information regarding Merck and Santen
The Merck is a huge world wide healthcare company. The Merck works with more than 140 countries to give them health solutions. The Santen Is a pharmacy company which has its base in Osaka and works in fields ophthalmic, eyesight, and health.
No comments:
Post a Comment